Clinical chemistry substrate IVDs

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Mevcut itibaren:

Radiometer Pacific Pty Ltd

Sınıf:

Class 2

Tarafından üretildi:

OSANG Healthcare Co Ltd 132 Anyangcheondong-ro Dongan-gu Anyang-si, Gyeonggi-do, 14040 Korea - Republic of

Terapötik alanı:

CT833 - Clinical chemistry substrate IVDs

Terapötik endikasyonlar:

The HemoCue HbA1c 501 System is a point of care device which provides a convenient method for measuring the percentage of haemoglobin A1c (HbA1c%) in both capillary and anticoagulated venous whole blood samples. The HemoCue HbA1c 501 system is intended to be used by professionals in laboratories, clinics and hospitals.

Yetkilendirme durumu:

A

Yetkilendirme tarihi:

2013-03-13